Future investigations should delve deeper into the glycolytic pathway and the intricate regulatory mechanisms of PGK1 in breast cancer progression, with the aim of providing a more robust scientific foundation for personalized treatment and prognosis evaluation in breast cancer. The gene discussed is PGK1; the disease is breast carcinoma.